SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

21 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 1.46 million declined by -96.77% from Rs. 45.21 millions.A radical decline of -93.40% was reported in the net profit of the company for the quarter ended March 2022 to Rs. 0.34  millions from Rs. 5.15 millions.Operating Profit reported a sharp decline to 5.27 millions from 13.40 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1.46 45.21 -96.77 3.65 69.91 -94.78 3.65 69.91 -94.78
Other Income 7.06 3.63 94.49 19.19 14.66 30.90 19.19 14.66 30.90
PBIDT 5.27 13.40 -60.67 10.25 23.12 -55.67 10.25 23.12 -55.67
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 5.27 13.40 -60.67 10.25 23.12 -55.67 10.25 23.12 -55.67
Depreciation 0.37 0.15 146.67 0.92 0.58 58.62 0.92 0.58 58.62
PBT 4.90 13.25 -63.02 9.33 22.54 -58.61 9.33 22.54 -58.61
TAX 4.56 8.10 -43.70 4.57 8.05 -43.23 4.57 8.05 -43.23
Deferred Tax 0.22 4.48 -95.09 0.22 4.48 -95.09 0.22 4.48 -95.09
PAT 0.34 5.15 -93.40 4.76 14.49 -67.15 4.76 14.49 -67.15
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 360.96 29.64 1117.83 280.82 33.07 749.15 280.82 33.07 749.15

Emmessar Biotech&Nut Share Price

26.29 -0.70 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×